heart failure pharmacology Flashcards
drugs effect heart function both..
- directly - force of contraction/ rhythm
- indirectly - vsascualture by altering blood volume and composition
outline the first line of therapy
- beta blockers in conjunction
- ACE inhibitors
- Diuretics
- MRAs (K sparring)
outline the second line of therapy
- digitalis (inhibits Na/K ATTase)
- entresto (sacubitril + valsartan)
- ivabridine (funny current blocker)
Outline the mechanism of beta-blockers
- metoprolol & carvedilol
- inhibit SNS innveration via blocking B1r
reduces - chronotropy
- isotropy (contractility)
- dromotropy (conduction)
- Lusitropy (relaxation)
- minimal effect on vasculature
- preservation of ATP/ reduces work load and energy requirement
Outline the mechanism of ACE inhibitors -
- Benazepril & Captopril
- produce vasodilation of vasculature by inhibiting formation of ag2
- treat chronic HT
- used in conjunction with diuretics
AT1r blockers work by? (ARBs)
The sartans - eprosartan & Valsartan
- bind to AT1r on vessels
- inhibits IP3 pathway involved in increasing ca levels and therefore contraction. of smooth muscle around vasculature
- stimulates Ca release from L-T/ SR
Loop diuretics work how?
Bumetanide & Edecrin
- most powerful
- targets the NKCC2 channel in the loop of Henle (thick ascending limb)
- transporter absorbs 25% of Na load
- loss of na/water
- hypoK, alkalosis
- increased ca loss
Thiazides target the?
- inhibit the Na/Cl symporter in DCT
- 10% of Na reabsorbed so not very effective
- increased ca absorption
K -sparring diuretics work by?
- act as antagonists of the MR present on epithelial cells of the CD
- increased water loss in urine
- inhibits insertion of preformed Na channels within apical membrane and Na/K atpases + synthesis
- weak natriuresis
- prevents XS loss of K (no hypoK)
Natriuretic peptides work via?
ANP, BNP
- elevating cGMP synthesis in smooth muscle of vessels leading to vasodilation
natriuretic peptides are produced in response to?
- stretch
- ag2
- endothelia levels
- SNS activity
nesirtide (recombinant BNP)
CV and renal action of NPs include?
- natriuresis
- diuresis
- elevated GFR /filtration fraction
- reduced circulating ag2
- reduced circulating aldosterone
- systemic VD
- arterial hypotension
- reduced venous pressure
sacubitril works how?
- blocker of neprilysin
- enzyme that degrades NP
- effective when given in conjunction with ARB valsartan
what is the benefit of funny current inhibitors ?
- funny current carried by hyperpol activated cyclic nucleotide gated Chanel (HCN)
- inhibition slows AP firing rate
- reduced HR and preservation of ATP in myocyte cells
what are the 2 types of nitro dilators?
- those that release NO spontaneously (Na nitroprusside)
- organic nitrates that require enzymatic processes to form NO
- tolerance occurs with frequent dosing
- work via elevating cGMP levels, up regulating K channels expression , stimulation of MLCP and inhibition of IP3 pathway
- all aim to produce VD in smooth muscle
Name a cardiostimulatory drug
- cardiac glycosides
- sympathomimetics
- PDE inhibitors
name an example of a cardiac glycoside drug and explain how it works
- digitalis compounds - digoxin
- inhibitors of ATPase pump
- rises Na levels in the cell
- reduced external driving force on Na
- so this leads to reduced ca efflux via the NCX channel (anti porter)
- elevated intracellular levels of ca
- increased contractility
- increased EF and HR
Name some negative side effects of digitalis compounds
- arrhythmias
- diastolic dysfunction
- hypertrophy
- fibrosis
How do PDE inhibitors work? (in periphery)
- inhibit PDE3 in the smooth muscle vessel cells
- increased levels of cAMP via reduced degradation
- stimulation of MLCP
- inhibits MLCK
- vasodilation
- decreased systemic resistance
- decreased arterial BP
The effects of PDE5 on cardiopulmonary system?
- increased cAMP
- increased contractility and HR
- increased SV and EF
- decreased V preload
Non- pharmacological approaches include
- CRISPR cas 9 system
- SERCA2A gene transfer via CUPID2 (often down regulated in HF)
- increases lucitropy
- pluripotent stem cell derived cardiomyocytes
- cardiac assist devices - implantations of a LV assist device